JB Chemicals gets USFDA nod for drug to treat Pollen allergy

This drug is for treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy

117
Medicine
Picture: Pixabay

Last Updated on January 9, 2021 by The Health Master

NEW DELHI: JB Chemicals and Pharmaceuticals on Friday said it has received approval from the US health regulator to market Loratadine tablets, used to treat allergies, in the American market.

The US Food and Drug Administration (USFDA) has approved company’s abbreviated new drug application (ANDA) for Loratadine tablets USP 10 mg.

This drug is for treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy, JB Chemicals and Pharmaceuticals said in a regulatory filing.

JB Chemicals’ product is a generic version of Bayer Healthcare’s Clartin tablets.

“The company expects to commercialise this product in the first quarter of 2021-22 and is expected to improve its US sales,” the drug firm noted.


Also read | Lupin gets USFDA approval for bacterial infection drug


The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.

Follow and connect with us on Facebook and Linkedin

Go to main website, click here

Subscribe for daily free updates, click here